Molecular Diagnostic Services (MolDX)
The Molecular Diagnostic Services (MolDX) Program was developed by Palmetto GBA in 2011 to identify and establish coverage and reimbursement for molecular diagnostic tests. This program performs the following functions.
- Facilitates detailed and unique identification through registration of molecular diagnostic tests to facilitate claims processing and to track utilization.
- Establishes clinical utility expectations.
- Completes technical assessments of published test data to determine clinical utility and coverage.
- Establishes reimbursement.
View the MolDX Approved Molecular Tests for Reimbursement [PDF]
View the MolDX Molecular Test Registration and Claims Submission [PDF]
View the Molecular Diagnostic Program (MolDX®) Manual [PDF]
Palmetto GBA currently administers the MolDX Program and all its information.
Active LCDs - View all active Local Coverage Determinations (LCDs)
Covered Tests - View MolDX LCDs and LCD Articles
Excluded Tests - View MolDx tests excluded from coverage
Draft LCDs - View all draft LCDs
Future LCDs - View all future LCDs
|MolDX Contractor||Noridian||Providers in Noridian's Jurisdictions|
| || || |
Last Updated Mar 14, 2018